COMPANY PROFILE
| Price and Volume | |
|---|---|
| Recent Price | 36.90 |
| 52 Week High | 40.78 |
| 52 Week Low | 27.21 |
| Avg. Daily Vol. (Mil) | 6.70 |
| Beta (3 year) | 0.83 |
| Share Related Items | |
| Mkt Cap (Mil) | 42,398.93 |
| Shares Out (Mil) | 1,149.02 |
| Float (Mil) | 1,146.87 |
| Dividend Information | |
| Yield % | 5.30 |
| Annual Dividend | 1.96 |
| Payout Ratio | N.A. |
| Financial Strength | |
| Quick Ratio | 1.20 |
| Current Ratio | 1.90 |
| LT Debt/ Equity | 0.68 |
| Total Debt / Equity | 0.75 |
| Valuation Ratios | |
| Price Earnings | N.A. |
| Price/Sales | 2.01 |
| Price/Book | 4.28 |
| Price/Cash Flow | 43.00 |
| Per Share Data | |
| Earnings | -0.19 |
| Sales | 18.37 |
| Book Value | 8.62 |
| Cash Flow | 0.86 |
| Business Summary | |
|---|---|
| The Company discovers, develops, manufactures and sells products in one segment of pharmaceutical products. | |
| General Information | |
| Lilly Corporate Center
Indianapolis, IN 46285 |
|
| www.lilly.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 40450 | |
| CEO: Dr. John C. Lechleiter, | |
| Short Interest | |
| Current Month (Mil) | 29.37 |
| Previous Month (Mil) | 29.66 |
| Short Interest Ratio (Days) | 3.90 |
| Management Effectiveness | |
| Return on Equity | N.A. |
| Return on Assets | -0.80 |
| Return on Investments | -1.30 |
| Profitability | |
| Gross Margin | 88.00 |
| EBIT Margin | 5.60 |
| Profit Margin | -1.00 |